Fiche personne


Territoire

Bourgogne

Statut

Hospitalier

Recherche

Expertises :
- Clinique:Dermatologie

Projets


Publications


A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations.

Ródon J, Arkenau HT, Funchain P, Hervieu A, Anthony K, Chawla SP, Laetsch TW, Murciano-Goroff YR, Singer CF, He Y, Mina M, Wacheck V, Delaloge S

ESMO Open. 2025 12 30;11(1):105932

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.

Borcoman E, Hervieu A, Cropet C, Coquan E, Guigay J, Rolland F, Bernadach M, Charafe E, Legrand F, Dassé E, Le Tourneau C, Gonçalves A

ESMO Open. 2025 11 5;10(11):105840

Pemigatinib for Previously Treated Metastatic or Unresectable Central Nervous System Tumors with FGFR Mutations or Rearrangements: FIGHT-207 Results.

Spanggaard I, Matrana M, Lima CR, Mahipal A, Vieito M, Hervieu A, Goyal L, Rodón J, Veronese ML, Oliveira N, Li X, Schaffer M, Kesari S

Oncologist. 2025 10 16;:

Voir plus